|
WDR53 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.501100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.910400E-02 |
| Normal-vs-Stage2 |
2.706000E-01 |
| Normal-vs-Stage3 |
9.229000E-01 |
| Normal-vs-Stage4 |
9.521800E-01 |
| Stage1-vs-Stage2 |
9.934200E-01 |
| Stage1-vs-Stage3 |
1.696990E-01 |
| Stage1-vs-Stage4 |
3.592800E-01 |
| Stage2-vs-Stage3 |
3.788800E-01 |
| Stage2-vs-Stage4 |
4.950000E-01 |
| Stage3-vs-Stage4 |
9.953800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.721700E-03 |
| Normal-vs-AfricanAmerican |
1.211020E-01 |
| Normal-vs-Asian |
2.108600E-01 |
| Caucasian-vs-AfricanAmerican |
3.081200E-01 |
| Caucasian-vs-Asian |
6.310600E-01 |
| AfricanAmerican-vs-Asian |
3.423000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.599300E-03 |
| Normal-vs-Female |
2.471700E-02 |
| Male-vs-Female |
8.440800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.316800E-01 |
| Normal-vs-Extreme_Weight |
2.175600E-02 |
| Normal-vs-Obese |
1.723550E-02 |
| Normal-vs-Extreme_Obese |
3.462400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.370400E-01 |
| Normal_Weight-vs-Obese |
1.024590E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.423200E-01 |
| Extreme_Weight-vs-Obese |
8.208200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.550200E-01 |
| Obese-vs-Extreme_Obese |
8.630600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.786300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.978800E-04 |
| Normal-vs-Age(61-80Yrs) |
6.104000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.911400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.847200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.134200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.020230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.902500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.151600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.632220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.27019999998745E-06 |
| Normal-VS-Type2 PRCC |
1.681190E-01 |
| Normal-VS-KIRP CIMP |
7.718600E-01 |
| Normal-VS-Unclassified PRCC |
1.245230E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.93960000575089E-09 |
| Type1 PRCC-VS-KIRP CIMP |
3.658600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.933600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.555970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.271640E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.287600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.199800E-01 |
| Normal-vs-N1 |
2.587400E-01 |
| Normal-vs-N2 |
8.311800E-01 |
| N0-vs-N1 |
4.381400E-01 |
| N0-vs-N2 |
7.914400E-01 |
| N1-vs-N2 |
6.762000E-01 |
|
|
